Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PROCTER & GAMBLE HEALTH vs VENUS REMEDIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PROCTER & GAMBLE HEALTH VENUS REMEDIES PROCTER & GAMBLE HEALTH/
VENUS REMEDIES
 
P/E (TTM) x 39.3 18.1 217.5% View Chart
P/BV x 16.2 0.8 1,973.6% View Chart
Dividend Yield % 5.0 0.0 -  

Financials

 PROCTER & GAMBLE HEALTH   VENUS REMEDIES
EQUITY SHARE DATA
    PROCTER & GAMBLE HEALTH
Jun-24
VENUS REMEDIES
Mar-24
PROCTER & GAMBLE HEALTH/
VENUS REMEDIES
5-Yr Chart
Click to enlarge
High Rs5,640430 1,312.8%   
Low Rs4,640163 2,848.6%   
Sales per share (Unadj.) Rs693.5449.9 154.2%  
Earnings per share (Unadj.) Rs121.121.3 568.2%  
Cash flow per share (Unadj.) Rs137.641.1 334.8%  
Dividends per share (Unadj.) Rs260.000-  
Avg Dividend yield %5.10-  
Book value per share (Unadj.) Rs319.1364.7 87.5%  
Shares outstanding (eoy) m16.6013.37 124.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x7.40.7 1,125.6%   
Avg P/E ratio x42.513.9 305.4%  
P/CF ratio (eoy) x37.47.2 518.3%  
Price / Book Value ratio x16.10.8 1,983.2%  
Dividend payout %214.70-   
Avg Mkt Cap Rs m85,3233,960 2,154.6%   
No. of employees `000NANA-   
Total wages/salary Rs m2,152669 321.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m11,5136,015 191.4%  
Other income Rs m156116 135.0%   
Total revenues Rs m11,6696,130 190.3%   
Gross profit Rs m2,858596 479.5%  
Depreciation Rs m274264 103.6%   
Interest Rs m71 766.0%   
Profit before tax Rs m2,733446 612.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m723162 447.8%   
Profit after tax Rs m2,010285 705.4%  
Gross profit margin %24.89.9 250.5%  
Effective tax rate %26.536.2 73.2%   
Net profit margin %17.54.7 368.5%  
BALANCE SHEET DATA
Current assets Rs m9,3063,595 258.8%   
Current liabilities Rs m6,253794 787.4%   
Net working cap to sales %26.546.6 56.9%  
Current ratio x1.54.5 32.9%  
Inventory Days Days29828 1,049.0%  
Debtors Days Days271489 55.4%  
Net fixed assets Rs m10,7352,673 401.6%   
Share capital Rs m166134 124.2%   
"Free" reserves Rs m5,1314,742 108.2%   
Net worth Rs m5,2974,876 108.6%   
Long term debt Rs m0387 0.0%   
Total assets Rs m20,0416,268 319.7%  
Interest coverage x380.6475.9 80.0%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x0.61.0 59.9%   
Return on assets %10.14.6 220.7%  
Return on equity %37.95.8 649.3%  
Return on capital %51.78.5 608.5%  
Exports to sales %00-   
Imports to sales %69.60-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m8,013NA-   
Fx inflow Rs m5,4210-   
Fx outflow Rs m8,0130-   
Net fx Rs m-2,5920-   
CASH FLOW
From Operations Rs m2,283373 612.3%  
From Investments Rs m-69-72 95.3%  
From Financial Activity Rs m-4,181-11 38,606.6%  
Net Cashflow Rs m-1,967277 -708.9%  

Share Holding

Indian Promoters % 0.0 41.8 -  
Foreign collaborators % 51.8 0.0 -  
Indian inst/Mut Fund % 21.5 1.2 1,817.8%  
FIIs % 6.6 1.2 560.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.2 58.2 82.7%  
Shareholders   54,792 19,557 280.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PROCTER & GAMBLE HEALTH With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    MANKIND PHARMA    


More on Procter & Gamble Health vs VENUS REMEDIES

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Procter & Gamble Health vs VENUS REMEDIES Share Price Performance

Period Procter & Gamble Health VENUS REMEDIES S&P BSE HEALTHCARE
1-Day 1.23% 2.23% 0.90%
1-Month 3.30% -8.07% 1.22%
1-Year -0.36% -23.22% 46.21%
3-Year CAGR 0.84% -11.84% 19.63%
5-Year CAGR 3.97% 66.83% 26.12%

* Compound Annual Growth Rate

Here are more details on the Procter & Gamble Health share price and the VENUS REMEDIES share price.

Moving on to shareholding structures...

The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of VENUS REMEDIES the stake stands at 41.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of VENUS REMEDIES.

Finally, a word on dividends...

In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 260.0 per share. This amounted to a Dividend Payout ratio of 214.7%.

VENUS REMEDIES paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of VENUS REMEDIES.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Zooms Over 1,200 Points | Nifty Above 24,300 | Adani Ports Climbs 4% Sensex Today Zooms Over 1,200 Points | Nifty Above 24,300 | Adani Ports Climbs 4%(10:30 am)

Asian stocks experienced a notable rally alongside US equity futures on Monday, marking a positive turn for the markets. The dollar retreated against other currencies as bond yields declined.